Latest news with #ALM
Yahoo
2 days ago
- Sport
- Yahoo
Sky Blues ace seals English Championship move
A-League Men star Adrian Segecic is off to Europe after snaring a move to English Championship side Portsmouth. Sydney FC were keen to retain the services of the highly-rated forward, but the lure of a three-year contract proved too strong. The 21-year-old will reunite with former Sky Blues teammate Hayden Matthews at the English club, as well as fellow ALM talents Jacob Farrell (Central Coast Mariners) and Thomas Waddingham (Brisbane Roar). "Adrian is a really exciting young player – one of the hottest prospects coming out of Australia at the moment," Portsmouth boss John Mousinho told the club website. "We've already had some success with bringing people over from that part of the world and we hope that Adrian can now make a real impact at Pompey." Sega speaks. 🗣️ — Portsmouth FC (@Pompey) June 18, 2025 Segecic leaves as the reigning Golden Boot winner, scoring 13 goals in 24 matches this season. His move gifts Sydney FC a substantial six-figure fee in compensation for the Young Socceroos midfielder. Segecic said the move came at the right time after nine years at the club. "I'm honestly devastated to be leaving Sydney FC – this club has been my home for almost a decade," Segecic said in a club statement. "But I know I have to test myself and find out how far I can take my career. "I'm so excited for what's ahead of me in England, but I'll always be grateful to Sydney FC for the incredible opportunities they've given me." Segecic lit up the ALM after a loan spell at Dutch club FC Dordrecht last season. He has scored 24 goals in 65 Sky Blues appearances across all competitions. Sydney coach Ufuk Talay could only praise Segecic, keeping his fingers crossed on a potential return in the future. "His hunger to improve and his desire to perform every week really stood out - he absolutely deserves this opportunity," Talay said. "While we would have loved to keep him ... he's determined to test himself in one of the toughest leagues in world football, and we're proud that our pathway has enabled him to do that. "He's a homegrown boy done good, and we'd love to see him back in Sky Blue one day."
Washington Post
5 days ago
- Health
- Washington Post
Too often, Black patients get late diagnoses of deadly skin cancer
Consumer Reports has no financial relationship with any advertisers on this site. The abundance in Black skin of melanin, the pigment that gives skin its color, offers extra protection from damaging ultraviolet rays. That makes Black people less likely than White people to get melanoma, the most dangerous skin cancer. But that fact comes with a tragic footnote: Black people who are diagnosed with melanoma are about five times as likely as White people to die within five years. That dramatic difference is largely the result of late diagnoses, likely caused in large part by a lack of awareness about how melanoma typically presents on Black bodies. If we know how and where to look for the disease, in other words, fewer of us will die of it. Reggae pioneer Bob Marley's death at the age of 36 is a cautionary tale of delayed detection. A dark spot under his toenail that Marley believed to be the result of a soccer injury was eventually diagnosed as acral lentiginous melanoma. ALM is an aggressive cancer that usually appears as a freckle or dark brown spot or patch on the palms or the soles of the feet, or as a band running lengthwise under a nail — rather than on parts of the body that are more exposed to sunlight, where melanoma is usually found on lighter skin. Though it can occur in anyone, ALM is the most common type of malignant melanoma among people with darker skin tones. Why does ALM often go unrecognized until it's too late? For starters, the characteristics of ALM aren't covered under the widely disseminated early detection strategy known as the ABCDEs of melanoma, which since 1985 has encouraged the public to check for moles that are: Asymmetrical; have blurry, scalloped or jagged Borders; are multi- or haphazardly Colored; are larger than 6 millimeters in Diameter (a little bigger than a pencil eraser); or Evolve in size, shape or feeling. (ALM has its own diagnostic acronym, which we'll get to below.) Dermatologists should know to look for ALM, of course, especially when examining people of color. But it seems the medical community may not be doing a good enough job spreading the word among practitioners. A 2012 study in the journal Dermatology Clinic reported that in a recent survey, 47 percent of dermatologists and dermatology residents reported that their medical school or residency program offered inadequate training on skin conditions in Black people. It wasn't until a decade later that the American Academy of Dermatology introduced the Skin of Color Curriculum to train residents and practicing dermatologists on dermatologic conditions of the skin, hair and nails in patients with skin of color. The problem seems to be compounded by a consistent lack of images in dermatology textbooks and a lack of skin-of-color-focused articles in top dermatology journals. (When I did a Google image search using the query 'What does skin cancer look like?' I had to scroll through 10 pages of results before a single image of a Black person appeared.) 'Because there are a dearth of images of skin cancer on dark skin, doctors and patients are less aware of what it looks like, leading to delays in recognition and treatment,' says Adewole Adamson, board-certified dermatologist and assistant professor in the department of internal medicine at Dell Medical School at the University of Texas at Austin. Efforts are underway to address the issue. On Instagram, for example, Brown Skin Matters encourages its 118,000 followers to submit photos to create an image bank of what various dermatological conditions look like on skin of color. It was started by a mother who searched online for 'eczema on infant' and noticed that none of the images she found looked like her biracial son's symptoms. And in 2020, an international team of medical educators launched Skin Deep, a free, open-access medical education resource featuring photographs of dermatological conditions on a range of skin tones. A lack of diversity among dermatologists may also play a role in delaying ALM diagnoses. One 2020 JAMA study shows improved patient experience when physicians shared a racial/ethnic background with their patients. Yet only 3 percent of dermatologists in the United States are Black, while Black people make up 13 percent of the population. Regardless of the reasons for delayed ALM diagnoses, there are simple ways anyone can decrease their own risk. Early detection is key. Here's what to do: Perform regular self-checks. The AAD recommends using a full-length mirror to check your entire body for spots, moles, discoloration, rough or dry patches, and sores that won't heal or that heal and then return. A handheld mirror will let you examine hard-to-see areas like the top of the head, back, groin, buttocks and behind the ears. (You can also enlist help from a loved one.) And ask your barber or hairdresser to tell you if they notice any new or odd-looking growths or spots on your scalp. Check areas that usually are covered. Keep in mind that skin cancer in darker-skin populations most often develops on the soles of the feet, palms of the hands and nail beds, says Andrew Alexis, dermatologist at Weill Cornell Medicine. In 2010, a panel of podiatrists and dermatologists developed a clinical guide to aid in early identification of melanomas on the feet and nails known as CUBED, which is detailed below. The standard early detection strategy for spotting dangerous melanomas on the skin is not effective at detecting ALM, which typically manifests as a freckle or dark brown spot on the palms, soles of the feet or nail beds. To encourage early ALM detection, experts created the acronym CUBED. C: Colored lesions where any part is a different color. U: Uncertain diagnosis or a lesion without a clear clinical diagnosis. B: Bleeding lesions on the foot or under the nail. E: Enlargement of a lesion. D: Delay in healing of any lesion beyond two months. A few other things to keep in mind: Although it can occur on any toenail, ALM has a tendency to develop on the big toe, according to the AIM at Melanoma Foundation. Pay close attention to any narrow dark streaks in a nail not caused by an accident. On the surface of the foot, an ALM lesion could be flat, even as the tumor grows deep into the skin. The Foundation also cautions that thickening ALM is sometimes mistaken for a plantar wart on the sole of the foot and can make walking painful. Keeping a close watch on your own body parts is critical, but if you use a manicurist or pedicurist, they can also be helpful in spotting abnormalities on your hands and feet and under the nails. Find a dermatologist who is familiar with darker skin. Various institutions and individuals are working to bring dermatologists up to speed when it comes to communities of color. The Skin of Color Society is a member organization with a directory of physicians and board-certified dermatologists promoting awareness in skin-of-color dermatology. And there are a growing number of academic 'ethnic skin centers' in the U.S. that focus on the care and research of conditions common among people of color, preparing residents to treat skin of color and educating the medical community and public. Protect your skin from the sun. Recognizing that Black people tend to get melanomas on body parts that solar rays don't typically reach is important, but dark-skinned people still must protect themselves from direct sunlight. Even the darkest skin has a natural sun protection factor of only 13, according to the Dermatology Education Foundation — while the AAD recommends correct consistent use of broad-spectrum, water-resistant sunscreen with an SPF of at least 30. For some people of color, sunscreen is a hard sell. 'The acceptance of sunscreen use by people with skin of color has been at least in part affected by challenges finding sunscreen formulations that do not leave a visible cast,' Alexis says. Sunscreen can manifest on darker complexions as a white overtone that makes skin look like a powdered doughnut — but some are better than others in this respect. In a Consumer Reports evaluation, 83 people with olive to deep-brown complexions were asked to judge the look and feel of 21 sunscreens on their skin. The participants found several products that absorbed quickly and did not make their skin look chalky or ashy, including Black Girl Sunscreen Kids Spray & Play SPF 50 and Supergoop Play Everyday Lotion SPF 50. Of course, limiting your skin's exposure to the sun, by either staying in the shade or wearing protective clothing, can also mitigate the risk of developing skin cancer. Consumer Reports is an independent, nonprofit organization that works side by side with consumers to create a fairer, safer and healthier world. CR does not endorse products or services, and does not accept advertising. Read more at
Chicago Tribune
6 days ago
- Sport
- Chicago Tribune
Boston Red Sox trade Rafael Devers to San Francisco Giants in a blockbuster deal
BOSTON — The Boston Red Sox traded slugger Rafael Devers to the San Francisco Giants on Sunday in a deal that could shake up pennant races on both coasts. The Giants sent right-hander Jordan Hicks, lefty Kyle Harrison, outfield prospect James Tibbs III and minor-league righty Jose Bello to the Red Sox for the 28-year-old designated hitter, who had bristled at his demotion from third base this year. The Giants were one game behind the first-place Los Angeles Dodgers heading into Sunday night's matchup between the NL West rivals. San Francisco shortstop Willy Adames said on the ESPN broadcast that the team found out about 15 minutes before the game. 'Everybody's so excited,' he said in an on-field interview while playing the field in the second inning. 'Me, personally, I'm like thrilled to have him on the team. He's one of the best hitters in the game, and to have him on the team I think is going to help us do a lot of damage in the division. Obviously we need a bat like him in this lineup.' A three-time All-Star who signed a 10-year, $313.5 million contract with the Red Sox in 2023, Devers is batting .272 with 15 homers and 58 RBIs in 73 games, including a solo shot in Boston's 2-0 victory over the New York Yankees on Sunday that completed a three-game sweep. But his relationship with the team began to deteriorate when the team signed Gold Glove third baseman Alex Bregman during spring training and asked Devers to move to DH; he balked before agreeing to the switch. When first baseman Triston Casas sustained a season-ending knee injury, the Red Sox approached Devers about playing the field and he declined, saying the front office 'should do their jobs' and look for another player. A day after Devers' comments to the media about playing first, Red Sox owner John Henry, team president Sam Kennedy and chief baseball officer Craig Breslow flew to Kansas City to meet with Devers and manager Alex Cora. The situation became more difficult when Bregman sustained what the team called a significant right quadriceps injury May 23. 'Everybody around the league, I think, was paying attention to that. When any team is having some kind of drama like that, with a player like Devers — he basically was the face of the franchise,' Adames said before he was interrupted by Tommy Edman's home run that gave the Dodgers a 2-0 lead. 'We're thrilled to have him. Everybody's excited. So we're going to make him feel at home. I feel like it sends a message that we're going to compete. That we're going to do whatever it takes to come over here and win the division.' The Red Sox have won five out of six against the rival Yankees over the last two weekends to improve to 37-36, but they are still fourth in the AL East, 6½ games behind division-leading New York. Devers was 20 when he made his major-league debut with the Red Sox in 2017. He helped them win the 2018 World Series and led the team in RBIs for five consecutive seasons from 2020-24. He has finished in the top 20 in AL MVP voting five times. Devers is not the first Red Sox All-Star to be traded away: The team sent Mookie Betts to the Dodgers before the 2020 season in a salary dump — just a year after he won the AL MVP award and led Boston to a franchise-record 108 wins and its fourth World Series title since 2004. But the Devers deal is perhaps most reminiscent of the 2004 midseason shakeup when Boston traded disgruntled shortstop — and fan favorite — Nomar Garciaparra to the Chicago Cubs in a four-team deal. The Red Sox went on to win the World Series that year, ending their 86-year championship drought. This is the latest big move by Buster Posey, a seven-time All-Star who took over as San Francisco's president of baseball operations in September. He signed Justin Verlander to a one-year, $15 million contract in January and Adames to a seven-year, $182 million deal in December. 'It makes them better right now, for sure,' Dodgers pitcher Clayton Kershaw said in a TV interview from the dugout at Dodger Stadium. 'Buster Posey's really doing it. Good for Buster over there. He's going for it. I'd consider Raffy one of the top 10 hitters in the game, at worst. He's definitely a game-changer. It will be interesting to see what position he plays over there.' Harrison, 23, is 9-9 with a 4.48 ERA and 178 strikeouts in 39 games for the Giants over three seasons. Hicks, 28, was 5-12 with a 4.83 ERA and 139 strikeouts in 42 games over two seasons. Tibbs, 22, was the 13th pick in last year's draft; he is hitting .246 with 12 homers and 32 RBIs in 57 games for High-A Eugene of the Northwest League this season. Bello, 20, is 1-0 with a 2.00 ERA in eight games for the Giants rookie league team in Scottsdale, Ariz.
Miami Herald
10-06-2025
- Business
- Miami Herald
Arrive AI Secures Another Key Patent for its Smart Mailbox-Anchored Autonomous Last-Mile Delivery Solutions Platform
INDIANAPOLIS, INDIANA / ACCESS Newswire / June 10, 2025 / Arrive AI (NASDAQ:ARAI) - a pioneering autonomous delivery network anchored by Arrive Points™ - has obtained another U.S. patent for its artificial intelligence (AI) powered, smart mailbox platform designed for autonomous and conventional package delivery. The new patent is for the Arrive Points' ability to heat and cool items on demand and brings the company's total of issued U.S. patents to eight, with six more pending. "This element of our service delivery will be key for the healthcare industry for items like tissue samples and pharmaceuticals while also being a great convenience for other consumers," said Arrive CEO Dan O'Toole, who originally envisioned his product as supporting the retail product and food industries. "The potentially life-saving aspects of this service make this work so fulfilling and transformative for the healthcare industry. We're inspired every day by the improvements autonomous delivery can offer." The patent covers features hot and cold temperature control and preservation of goods before and after delivery; battery charging and exchange station; a collector to identify explosive materials, anthrax, etc...; ultraviolet system to eradicate disease, virus and harmful materials; an ozone applicator to eradicate disease, virus and harmful materials; weather monitoring; tag and track of vehicles and packages; facial recognition camera and software for pets and humans; and local two-way speakers; LED lights that strobe flash, and a flood light. "Continued focus on our intellectual property makes our Arrive Points more than just smart devices," O'Toole said. "We offer a brand-new platform with great potential for data tracking and other services, along with a universal access point for the entire autonomous logistics industry." O'Toole first filed for patent protection of his smart mailbox concept in 2014, edging Amazon by four days and other industry leaders by weeks. That foundational patent was secured in 2017. In addition to the basic design and temperature control element, Arrive AI's other U.S. patents cover drone delivery management and tethering, anti-theft mechanisms and intelligent chain-of-custody control. Arrive AI has 58 patents pending for its ALM solution filed across 22 countries and has secured several trademarks. See details at
Indianapolis Star
10-06-2025
- Business
- Indianapolis Star
Arrive AI Secures Another Key Patent for its Smart Mailbox-Anchored Autonomous Last-Mile Delivery Solutions Platform
INDIANAPOLIS, INDIANA / ACCESS Newswire Arrive AI (NASDAQ:ARAI) – a pioneering autonomous delivery network anchored by Arrive Points™ – has obtained another U.S. patent for its artificial intelligence (AI) powered, smart mailbox platform designed for autonomous and conventional package delivery. The new patent is for the Arrive Points' ability to heat and cool items on demand and brings the company's total of issued U.S. patents to eight, with six more pending. 'This element of our service delivery will be key for the healthcare industry for items like tissue samples and pharmaceuticals while also being a great convenience for other consumers,' said Arrive CEO Dan O'Toole, who originally envisioned his product as supporting the retail product and food industries. 'The potentially life-saving aspects of this service make this work so fulfilling and transformative for the healthcare industry. We're inspired every day by the improvements autonomous delivery can offer.' The patent covers features hot and cold temperature control and preservation of goods before and after delivery; battery charging and exchange station; a collector to identify explosive materials, anthrax, etc…; ultraviolet system to eradicate disease, virus and harmful materials; an ozone applicator to eradicate disease, virus and harmful materials; weather monitoring; tag and track of vehicles and packages; facial recognition camera and software for pets and humans; and local two-way speakers; LED lights that strobe flash, and a flood light. 'Continued focus on our intellectual property makes our Arrive Points more than just smart devices,' O'Toole said. 'We offer a brand-new platform with great potential for data tracking and other services, along with a universal access point for the entire autonomous logistics industry.' O'Toole first filed for patent protection of his smart mailbox concept in 2014, edging Amazon by four days and other industry leaders by weeks. That foundational patent was secured in 2017. In addition to the basic design and temperature control element, Arrive AI's other U.S. patents cover drone delivery management and tethering, anti-theft mechanisms and intelligent chain-of-custody control. Arrive AI has 58 patents pending for its ALM solution filed across 22 countries and has secured several trademarks. See details at -30- About Arrive AI: Arrive AI's patented Autonomous Last Mile (ALM) platform enables secure, efficient delivery to and from a smart, AI-powered mailbox, whether by drone, ground robot or human courier. The platform provides real-time tracking, smart logistics alerts and advanced chain of custody controls to support shippers, delivery services and autonomous networks. By combining artificial intelligence with autonomous technology, Arrive AI makes the exchange of goods between people, robots and drones frictionless and convenient. Its system integrates with smart home devices such as doorbells, lighting and security systems to streamline the entire last-mile delivery experience. Learn more at Cautionary Note Regarding Forward Looking Statements This news release and statements of Arrive AI's management in connection with this news release or related events contain or may contain 'forward-looking statements' within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements related to future events, which may impact our expected future business and financial performance, and often contain words such as 'expects', 'anticipates', 'intends', 'plans', 'believes', 'potential', 'will', 'should', 'could', 'would' ,'optimistic' or 'may' and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management's current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve significant known and unknown risks, uncertainties and other factors which may be beyond our control. Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. Potential investors should review Arrive AI's public filings for more complete information, including the risk factors that may affect future results, which are available for review at Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.
